It’s normal to see construction costs rise about 4% in a typical year — but 2025 was not a typical year.
Pending sales jumped more than 7% as buyers returned to Charlotte's housing market in January. But homes are taking longer to ...
Novo Nordisk on Tuesday announced plans to cut the list price of its popular diabetes and weight-loss drugs Ozempic and Wegovy by as much as 50% in the U.S. next year. The Danish drugmaker indicated ...
Weight loss drugmaker Novo Nordisk will cut the list prices of Ozempic and Wegovy by up to 50% beginning in 2027, the company announced on Tuesday. Wegovy currently carries a list price of $1,349 per ...
Novo Nordisk announced Tuesday it will be slashing the list price of its blockbuster GLP-1 medications, Ozempic, Wegovy and Rybelsus, by up to 50 percent beginning next year. Starting on Jan. 1, 2027, ...
Novo Nordisk on Tuesday said it plans to slash the monthly list prices of its popular obesity and diabetes drugs in the U.S. by up to 50% starting in 2027. The move aims to make the treatments more ...
COPENHAGEN, Feb 24 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab said on Tuesday it plans to slash the U.S. list prices of its blockbuster weight-loss drug Wegovy and diabetes ...
Novo Nordisk announced that it will significantly reduce the U.S. list prices of its widely used weight-loss drugs Wegovy, Ozempic and Rybelsus, starting Jan. 1, 2027. The company said all doses will ...
The weight-loss drugs that kicked off America's GLP-1 craze are about to get a lot less expensive, though only certain customers will notice the savings. Novo Nordisk said it will slash list prices of ...
Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results